Can a common blood pressure drug improve heart symptoms? new study investigates

NCT ID NCT06808321

ENROLLING_BY_INVITATION Disease control Sponsor: The Society of Prevention and Awareness of Cardiovascular Diseases Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study will follow 800 adults in Turkey with high blood pressure or chronic chest pain (angina) who are already taking benidipine. Researchers will track how well the drug controls blood pressure and eases chest pain symptoms over time. The goal is to see how benidipine works in everyday medical practice.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Benidipine (a calcium channel blocker for blood pressure and chest pain)
What this could lead to: If successful, this could confirm benidipine as an effective option for managing high blood pressure and angina in a real-world Turkish population.
What could go wrong: This is an observational study, not a controlled trial, so results may be influenced by other factors. It only includes patients already on benidipine, which may bias outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANGINA PECTORIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Angina Pectoris coronary artery disorder hypertensive disorder intermediate coronary syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANGINA PECTORIS CHRONIC CORONARY SYNDROME HYPERTENSION

Contacts and locations

Locations

Antalya Kepez State Hospital

Antalya, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.